Source: European Medicines Agency (EU)
DIASTABOL 50 mg tablets.
DIASTABOL 100 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to slightly pale yellow, round biconvex tablet. Diastabol 50 mg tablets are blank on one side and imprinted with “MIG 50” on the other side. Diastabol 100 mg tablets are blank on one side and imprinted with “MIG 100” on the other side. |
Each Diastabol 50 mg tablet contains: miglitol 50 mg.
Each Diastabol 100 mg tablet contains: miglitol 100 mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Miglitol |
Miglitol is a reversible inhibitor of intestinal alpha-glucosidases. Under the influence of miglitol, the digestion of complex carbohydrates into absorbable monosaccharides in the small intestine is dosedependently delayed. Administration of miglitol thus leads to reduced postprandial hyperglycaemia and a smoothing effect on fluctuations in the daily blood glucose profile. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Blister strips in hard cardboard outers comprising:
Pack sizes: 15, 20, 30, 50, 60, 90, 120, 240 tablets.
Not all pack sizes may be marketed.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
